Persistence of hepatitis E virus in the cerebrospinal fluid despite apparently successful ribavirin therapy

J Antimicrob Chemother. 2022 Jul 28;77(8):2300-2303. doi: 10.1093/jac/dkac147.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / therapeutic use
  • Drug Therapy, Combination
  • Hepatitis E virus*
  • Hepatitis E* / drug therapy
  • Humans
  • RNA, Viral
  • Ribavirin / therapeutic use

Substances

  • Antiviral Agents
  • RNA, Viral
  • Ribavirin